Skip to main content

Alectinib for Non Small Cell Lung Cancer User Reviews

Brand names: Alecensa

Rating: 9.7

Alectinib has an average rating of 9.7 out of 10 from a total of 3 reviews for the treatment of non small cell lung cancer. 100% of reviewers reported a positive experience, while 0% reported a negative experience.

10
67%
9
33%
8
0%
7
0%
6
0%
5
0%
4
0%
3
0%
2
0%
1
0%
  • lad...
  • Taken for 1 to 2 years
  • November 8, 2022

Alectinib "Taking for the last 12 months regularly, lungs have been cleared in PET CT report, some metastases are in the brain. Doctor advised me to continue for 4 months more. It is easy to swallow, but constipation is the main problem that occurred to me."

10 / 10
Was this helpful?YesNo
7 Report
  • Gar...
  • Taken for 2 to 5 years
  • May 24, 2025

"I was diagnosed with stage four lung cancer [ALK] 18 months ago and originally given a life expectancy of 5 months. All signs of cancer disappeared in three months after taking Alectinib. My last three scans have been clear! My current dose is three capsules twice a day. The treatment has had a number of side effects... severe lethargy, dizziness, initial severe shoulder pain, fluid retention, mild anemia, breathlessness, constipation, my liver blood tests showed some effect originally [I have now stopped drinking alcohol]. Ten minutes now is my limit for any physical activity, which is a significant improvement."

10 / 10
Was this helpful?YesNo
0 Report
  • Ker...
  • Taken for 6 months to 1 year
  • December 28, 2018

Alectinib "After using Optivo, 12 rounds of chemo, now Alecensa it has finally helped my stage 4 lung cancer. It has very few side effects compared to using other targeted and immunotherapy-related drugs."

9 / 10
Was this helpful?YesNo
21 Report

Frequently asked questions

See also:

Are you taking this medicine?

Your review helps others make informed decisions.
Write a review
Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.

Learn more about Non Small Cell Lung Cancer

Care guides